Jarosław Czyż (Jaroslaw Czyz)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Cell Cycle Arrest

Helicobacter Pylori Infection

Endoplasmic Reticulum Stress

Top Venues

Journal of translational medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Maciej Pudełek, Damian Ryszawy, Katarzyna Piwowarczyk, Sławomir Lasota, Zbigniew Madeja, Sylwia Kędracka-Krok, Jarosław Czyż
Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress. Journal of translational medicine 22 (1) (2024)
Maciej Pudełek, Damian Ryszawy, Katarzyna Piwowarczyk, Sławomir Lasota, Zbigniew Madeja, Sylwia Kędracka-Krok, Jarosław Czyż
Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress. Journal of translational medicine 22 (1) (2024)
Anastasiia Pavlenko, Sławomir Lasota, Dawid Wnuk, Milena Paw, Jarosław Czyż, Marta Michalik, Zbigniew Madeja
Bronchial Fibroblasts from Asthmatic Patients Display Impaired Responsiveness to Direct Current Electric Fields (dcEFs). Biomedicines 11 (8) (2023)
Jarosław Czyż
Tracking the Routes of Cancer: The Microevolution of Cancer-Associated Fibroblasts. Cancers 15 (21) (2023)
Karolina W Warzecha, Maciej Pudełek, Jessica Catapano, Zbigniew Madeja, Jarosław Czyż
Long-Term Fenofibrate Treatment Stimulates the Phenotypic Microevolution of Prostate Cancer Cells In Vitro. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Jessica Catapano, Marcin Luty, Tomasz Wróbel, Maciej Pudełek, Katarzyna Piwowarczyk, Sylwia Kędracka-Krok, Maciej Siedlar, Zbigniew Madeja, Jarosław Czyż
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress. Cellular & molecular biology letters 27 (1) (2022)
Ewelina Madej, Damian Ryszawy, Anna A Brożyna, Małgorzata Czyż, Jarosław Czyż, Agnieszka Wolnicka-Glubisz
Deciphering the Functional Role of RIPK4 in Melanoma. International journal of molecular sciences 22 (21) (2021)
Paweł Kochanowski, Jessica Catapano, Maciej Pudełek, Tomasz Wróbel, Zbigniew Madeja, Damian Ryszawy, Jarosław Czyż
Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)+ Glioblastoma Cells in a Snail-1/Cx43-Dependent Manner. International journal of molecular sciences 22 (8) (2021)
Tomasz Wróbel, Marcin Luty, Jessica Catapano, Elżbieta Karnas, Małgorzata Szczygieł, Katarzyna Piwowarczyk, Damian Ryszawy, Grażyna Drabik, Ewa Zuba-Surma, Maciej Siedlar, Zbigniew Madeja, Martyna Elas, Jarosław Czyż
CD44+ cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations. Stem cells (Dayton, Ohio) (2020)
Maciej Cieślak, Damian Ryszawy, Maciej Pudełek, Magdalena Stolarska, Maja Morawiak, Olga Staszewska-Krajewska, Jarosław Czyż, Zofia Urbańczyk-Lipkowska
Bioinspired Bola-Type Peptide Dendrimers Inhibit Proliferation and Invasiveness of Glioblastoma Cells in a Manner Dependent on Their Structure and Amphipathic Properties. Pharmaceutics 12 (11) (2020)
Gracjana Krzysiek-Maczka, Aneta Targosz, Urszula Szczyrk, Tomasz Wrobel, Malgorzata Strzalka, Tomasz Brzozowski, Jarosław Czyż, Agata Ptak-Belowska
Long-Term Helicobacter pylori Infection Switches Gastric Epithelium Reprogramming Towards Cancer Stem Cell-Related Differentiation Program in Hp-Activated Gastric Fibroblast-TGFβ Dependent Manner. Microorganisms 8 (10) (2020)
Urszula Gawlik-Dziki, Marcin Luty, Dariusz Dziki, Michał Świeca, Katarzyna Piwowarczyk, Urszula Złotek, Jarosław Czyż
Cytoprotective Compounds Interfere with the Nutraceutical Potential of Bread Supplemented with Green Coffee Beans. Antioxidants (Basel, Switzerland) 8 (7) (2019)
Marcin Luty, Katarzyna Piwowarczyk, Anna Łabędź-Masłowska, Tomasz Wróbel, Małgorzata Szczygieł, Jessica Catapano, Grażyna Drabik, Damian Ryszawy, Sylwia Kędracka-Krok, Zbigniew Madeja, Maciej Siedlar, Martyna Elas, Jarosław Czyż
Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel. Cancers 11 (1) (2019)